AACHEN, Germany, March 1, 2023 /PRNewswire/ Janneke van der Kamp has today assumed her role as the new Chief Commercial Officer (CCO) of Grünenthal. She joins Grünenthal's executive board
The Joint Venture Collaboration includes a portfolio of 13 life-changing brands across six therapeutic areas, with revenues primarily resulting from pain management medicines The collaboration
- Five promising early-career scientists have been awarded the prestigious EFIC-Grünenthal Grant (E-G-G) 2022 - The E-G-G funds innovative research projects to advance understanding of
/PRNewswire/ The European Pain Federation EFIC® and the pharmaceutical company Grünenthal have announced the five recipients of the EFIC-Grünenthal Grant.